Cardiovascular complications in patients with chronic renal insufficiency and chronic renal failure;Kardiovaskulární komplikace u pacientů s chronickou renální insuficiencí a chronickým selháním ledvin

Vnitrni Lekarstvi

Volumn 49, Issue 5, 2003, Pages 383-387

  Tesaŕ, Vladimir ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Atherosclerosis; Cardiovascular complications; Cardiovascular mortality; Chronic renal failure; Chronic renal insufficiency; Hyperhydratation; Left ventricular hypertrophy; Uraemia; Uraemic cardiomyopathy

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANEMIA; ARTICLE; ATHEROSCLEROSIS; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DYSLIPIDEMIA; GLOMERULUS FILTRATION; HEART DILATATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MORTALITY; REMISSION; UREMIA;

CARDIOVASCULAR DISEASES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; RISK FACTORS;

EID: 0038124736     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Benedetto, F. A., Mallamaci, F., Tripepi, G. et al.: Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J. Am. Soc. Nephrol. 2001; 12: 2458-2464
2. Cannella, G., Paoletti, E., Ravera, G. et al.: Inadequate diagnosis and therapy of arterial hypertension as causes of left ventricular hypertrophy in uremic dialysis patients. Kidney Int., 2000; 58: 260-268
3. Cannella, G., Paoletti, E., Delfino, R. et al.: Prolonged therapy with ACE inhibitors induces a regression of left ventricular hypertrophy of dialyzed uremic patients independently from hypotensive effects. Am. J. Kidney Dis., 1997; 30: 659-664
4. Cannella, G., Paoletti, E., Barocci, S. et al.: Angiotensin-converting enzyme gene polymorphism and reversibility of uremic left ventricular hypertrophy following long-term antihypertensive therapy. Kidney Int., 1998; 54: 618-626
5. Clase, C. M., Garg, A. X., Kiberd, B. A.: Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J. Am. Soc. Nephrol., 2002; 13: 1338-1349
6. Couser, W. G.: Chronic Kidney Disease - How many have it? J. Am. Soc. Nephrol., 2002; 13: 2810
7. Culleton, B. F., Larson, M. G., Wilson, P. W. et al.: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int., 1999; 56: 2214-2219
8. de Leeuw, P. W., Thijs, L., Birkenhager, W. H. et al.: Prognostic significance of renal function in elderly patients with isolated systolic hypertension: results from the Syst-Eur trial. J. Am. Soc. Nephrol., 2002; 13: 2213-2222
9. Foley, R. N., Parfrey, P. S., Sarnak, M.: Epidemiology of cardiovascular disease in chronic renal failure. Am. J. Kidney Dis., 1998; 32 (Suppl. 3): S12-S19
10. Foley, R. N., Parfrey, P. S., Kent, G. M. et al.: Long-term evolution of cardiomyopathy in dialysis patients. Kidney Int., 1998; 54: 1720-1725
11. Foley, R. N., Parfrey, P. S., Harnett, J. D. et al.: The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J. Am. Soc. Nephrol., 1995; 5: 2024-2031
12. Foley, R. N., Parfrey, P. S., Morgan, J. et al.: Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney Int., 2000; 58: 1325-1335
13. Garg, A. X., Clark, W. F., Haynes, B. et al.: Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int., 2002; 61: 1486-1494
14. Henry, R. M. A., Kostense, P. J., Bos, G. et aL: Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int., 2002; 62: 1402-1407
15. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification. Am. J. Kidney Dis., 2002; 39 (Suppl. 1): S1-S266
16. Levin, A., Thompson, C. R., Ethier, J. et al: Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am. J. Kidney Dis., 1999; 34: 125-134
17. Levey, A. S., Beto, J. A., Coronado, B. E. et al.: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am. J. Kidney Dis., 1998; 32: 853-906
18. London, G. M., Pannier, B., Guerin, A. P. et al.: Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J. Am. Soc. Nephrol., 2001; 12: 2759-2767
19. Mann, J. F. E., Gerstein, H. C., Pogue, J. et al.: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann. Intern. Med., 2001, 134: 629-636
20. Muntner, P., He, J., Hamm, L. et al.: Renal insufficiency and subsequent death resultin from cardiovascular disease in the United States. J. Am. Soc. Nephrol., 2002, 13: 745-753
21. Parfrey, P. S., Harnett, J. D., Foley, R. N. et al.: Impact of renal transplantation on uremic cardiomyopathy. Transplantation, 1995, 60: 908-914
22. Ruilope, L. M., Salvetti, A., Jamerson, K. et al.: Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study. J. Am. Soc. Nephrol., 2001, 12: 218-225